NEW YORK / BOSTON – On Wednesday, UnitedHealth Group (NYSE: UNH) shareholders said they requested the company prepare a report
1 year ago
On Wednesday, Galapagos (NASDAQ: GLPG), the pharmaceutical firm, said it was planning to split into two listed entities by mid-2025,
ZURICH – On Wednesday, Roche said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics (NASDAQ: PSTX),
AMSTERDAM – Philips (NYSE: PHG), the healthcare technology company, has sold its Xiver computer chip subsidiary, the Telegraaf newspaper reported,
NEW YORK – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE: PFE) COVID-19
UnitedHealth Group (NYSE: UNH) and Amedisys (NASDAQ: AMED) have agreed to extend the deadline to close their $3.3 billion merger
BioNTech (NASDAQ: BNTX) has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to
U.S. retail investor fund flows into Novo Nordisk (NYSE: NVO) surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) revealed disappointing results in a late-stage trial for its experimental next-generation obesity
